Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2026-04-02 @ 11:18 AM
Study NCT ID:
NCT05121103
Status:
TERMINATED
Last Update Posted:
2025-06-22
First Post:
2021-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor:
Epizyme, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SET-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None